🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Penn Coronavirus symposium. slides now online from symposium last week. great clinical and cutting edge COVID-19 research youtube.com/playlist?list=…

Great article in the NYT from Gina Kolata. Nice analysis of what we know about immune heterogeneity and how it might relate to treatments How the Coronavirus Short-Circuits the Immune System - The New York Times nytimes.com/2020/06/26/hea…

We are so lucky to have you at the helm! Thanks for the leadership, inspiration, vision and steady hand in these challenging times.

AT 10 years I think we can say our first CAR T patient is cured.

Visionary philanthropist Barbara Netter has made a profound impact on science & medicine. With late husband Edward, they founded Alliance for Cancer Gene Therapy whose mission is to fund #celltherapy #genetherapy #research to empower pioneering and innovative scientists phillyfightscancer.org/2020/10/15/abo…

I've had it with gun violence. The husband of my 3rd cousin was shot and is now hemiplegic in a senseless drive by shooting. Yakima man hit in drive-by shooting while working in yard in Barge-Chestnut area | Crime And Courts | yakimaherald.com yakimaherald.com/news/crime_and…

brave scientists against Texas Bravo Tom Curran and Myles Brown: Two members of the highest-level review board of the Cancer Prevention and Research Institute of Texas have submitted their resignations from the board of the state-funded institute.

Was $NVS BELINDA #CARTCell #tcellrx vs SOC Phase III failure in #lymphoma due to manufacturing?? If 2% serum used in ex vivo media, acknowledged 2B inferior to 5% in #ASH21 poster 1768. 5% only used from end 2020 onwards. #lymsm #immunotherapy ash.confex.com/ash/2021/webpr…

Penn Patients with Decade-Long Leukemia Remissions after CAR T Cell Therapy Reveals New Details About Persistence of Personalized “Living Drug” Cells. Delighted to announce our study in Nature today

The June lab is excited to offer a postdoctoral position with a focus on T cell engineering and synthetic biology in the Center for Cellular Immunotherapies at the Perelman School of Medicine at the University of Pennsylvania.

10 years ago Emily Whitehead’s family got the news that she was cancer free. We wondered whether these #carTcells could keep her in remission and cure her disease without BMT. Now we know. 10 years from this transformative clinical experience, 5 years from FDA approval.

CAR T in Costa Rica

What can happen when #CARTcell Therapy Meets #ClonalHematopoiesis? @CarlHJune puts multiple scenarios InFocus Blood Cancer Discovery aacrjournals.org/bloodcancerdis…

thrilled that Bruce Levine to receive PMWC 2023 Pioneer Award. linkedin.com/posts/pmwcintl…

Tons of promising work using CAR T cells beyond cancer. Already showing signs of efficacy in early clinical reports. Check out our review in nature of this rapidly evolving field! W/ The Arany lab Baur Lab @jonepstein1 Carl June nature.com/articles/s4158…

x.com/sixers/status/… My lab in Spotlight at 76ers historic game when Embiid scored 70 points and set a franchise record for the 76ers. Penn Medicine

Anti-competitive practices of 10X genomics have forced Nanostring into chapter 11 restructuring. 10x has initiated litigation against not only Nanostring but also Vizgen, Curio Biosciences and Parse Biosciences. See below for more information: (genengnews.com/topics/biopers…)

wonderful work from Sonia guedan, former post doc. From her lab in Barcelona,j ust published in Nature Communications doi.org/10.1038/s41467…

Check out our latest paper, published Nature Communications. We show that STING activation induces IL18 secretion and thereby enhances CAR T function. Great collaboration between @CarlHJune lab and James Chen UT Southwestern Medical Center. Penn Medicine Penn Medicine MD Penn Postdoctoral Association nature.com/articles/s4146…